Evidence map›Paper›PMID 40508130›Full record

ArticleInternational journal of molecular sciences2025

Tripeptide-Loaded Liposomes as Multifunctional Components in Topical Formulations.

Michał Dymek, Maria José García-Celma, Elvira Escribano-Ferrer, Dawid Warszycki, Sławomir Kaźmierski, Łukasz Skoczylas, Małgorzata Tabaszewska, Elżbieta Sikora

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. LiposomalInternational journal of molecular sciences · 2026
    Article
  3. Enhanced encapsulation and membrane retention ofInternational journal of pharmaceutics: X · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Michał DymekCUT Doctoral School, Faculty of Chemical Engineering and Technology, Cracow University of Technology, 31-155 Kraków, Poland.
Maria José García-CelmaPharmaceutical Nanotechnology Group, Department of Pharmacy, Pharmaceutical Technology and Physical-Chemistry, University of Barcelona, E-08028 Barcelona, Spain.
Elvira Escribano-FerrerBiopharmaceutics and Pharmacokinetics Unit, Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, E-08028 Barcelona, Spain.
Dawid WarszyckiDepartment of Medicinal Chemistry, Maj Institute of Pharmacology, Polish Academy of Sciences, 31-343 Kraków, Poland.ORCID 0000-0002-2393-4709
Sławomir KaźmierskiCentre of Molecular and Macromolecular Studies, Polish Academy of Sciences, 90-363 Łódź, Poland.ORCID 0000-0002-5904-2630
Łukasz SkoczylasDepartment of Plant Product Technology and Nutrition Hygiene, Faculty of Food Technology, University of Agriculture in Kraków, 30-149 Kraków, Poland.ORCID 0000-0002-8349-4477
Małgorzata TabaszewskaDepartment of Plant Product Technology and Nutrition Hygiene, Faculty of Food Technology, University of Agriculture in Kraków, 30-149 Kraków, Poland.ORCID 0000-0001-9448-0612
Elżbieta SikoraFaculty of Chemical Engineering and Technology, Cracow University of Technology, 31-155 Kraków, Poland.ORCID 0000-0003-4867-965X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Modern dermocosmetics combine the effectiveness of active substances with the benefits of percutaneous penetration enhancers to address skin issues such as hyperpigmentation. In this study, three bioactive tripeptides (with amino acid sequences CSF, CVL, and CSN) with previously confirmed tyrosinase inhibition activity were synthesized using the solid-phase synthesis method. The structures of the obtained peptides were determined. In addition, elastase in silico and in vitro inhibition assays were carried out. The tripeptides were subsequently encapsulated into liposomes, for which key physicochemical parameters were determined, including size, zeta potential, and encapsulation efficiency. The average diameter of the prepared liposomes was approximately 100 nm across all samples. The prepared carriers were found to be stable and exhibited no cytotoxicity toward reconstructed human epidermis cells. The peptides achieved an encapsulation efficiency of approximately 20-30%, with no significant differences observed between the cationic and anionic vesicles. Liposomes containing the CSF tripeptide, which showed the strongest tyrosinase-inhibiting effect, did not transport the peptide through the human skin in an ex vivo assay to permit quantification in the receptor solution, but facilitated penetration and retention of the tripeptide within the epidermis (4.65 ± 1.81 μg/cm

Indexed as

LiposomesOligopeptidesAdministration, TopicalCosmeticsHumansMonophenol MonooxygenaseSkinSkin AbsorptionCosmeticsLiposomesMonophenol MonooxygenaseOligopeptidesbioactive tripeptidesencapsulationliposomesskin permeationtyrosinase inhibitors

Identifiers

PMID40508130
PMCPMC12154373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.